We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Biotech Settles False Claims Charges

Law360 (September 26, 2008, 12:00 AM EDT) -- The founder and chief investment officer of a California biotech firm that claimed it would have a cure for cancer within three years has settled U.S. Securities and Exchange Commission charges that they bilked investors out of $6.5 million by making false claims and fraudulent regulatory filings.

Matthew Sarad, the founder of Telomolecular Corp., and Jeremy Jobe, the company's CIO, did not admit or deny any of the allegations in the suit, which was filed and settled Thursday in U.S. District Court for the Eastern District...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.